Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Hits New 12-Month Low – Here’s What Happened

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $14.01 and last traded at $14.01, with a volume of 1911 shares changing hands. The stock had previously closed at $14.63.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on TLX shares. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group assumed coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 1.8 %

The business has a fifty day moving average of $15.63.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.